Hong Kong Stock Movement Update: BIOCYTOGEN-B surges 25%, Qian Xun Technology falls nearly 17%, attracting attention

In the past hour, the Hong Kong stock market has shown a clear divergence, with technology stocks and energy stocks performing particularly well. The strong rise of BIOCYTOGEN-B has attracted market attention, driving activity in related sectors. Meanwhile, the decline of Qian Xun Technology reflects cautious sentiment among investors, with short-term enthusiasm seemingly waning. Overall, the market has experienced significant volatility, with funds frequently switching preferences between strong stocks and underperforming stocks, creating a tight rhythm. The stock with the largest movement in the past hour, BIOCYTOGEN-B, surged 25.00%, becoming the market focus. Its strong performance has drawn a large influx of short-term funds, rapidly pushing its price up, and market sentiment has also surged, seemingly indicating investors' optimistic expectations for its future prospects. Strong stocks: 1. DINGYI GP INV: up 16.18%, with strong buying in the market, the stock price continues to rise, showing a preference for funds. 2. CHINA CBM: up 15.38%, benefiting from the recovery in energy demand, the stock price has been active, attracting attention from short-term funds. 3. YOFC: up 10.84%, against the backdrop of industry recovery, the stock price has steadily risen, and market sentiment is gradually warming. Underperforming stocks: 1. Qian Xun Technology: down 16.93%, lacking positive news recently, market sentiment has turned cautious, leading to pressure on the stock price. 2. CSPC PHARMA: down 10.48%, amid overall market volatility, this stock has shown weakness, with noticeable fund outflows